MARUX INC. is now offering common shares to the general public through an equity (Regulation-CF) crowdfunding platform in compliance with the Securities and Exchange Commission (SEC). The campaign is the first time MARUX™ is offering shares to the public at large, in parallel the company is also raising $25M through private sales of common shares to accredited investors.
The application will be the industry first real-time visual diagnostic tool for emergency medical responders and medical professionals. It is enhanced by machine learning (ML) together with artificial intelligence (AI) and augmented reality (AR), to help in all emergency assessments of physical injuries, vitals including Covid; fully secured by multiple U.S. patents and EU international patent applications.
This is the first set of European international patent applications related to the Company's software as a service (SaaS) process U.S. Patent application, which covers machine learning, artificial intelligence, and augmented reality.
MARUX, LLC announced that it has brought on a First Responders Advisor to its Board of Directors. Captain Larry Gambotto has over eighteen years of experience in emergency medical services and firefighting.
MARUX, LLC announced that it has placed a Board member to its Board of Directors for its Medical Advisor role. Dr. Kelly Dinnan, D.O. an American Medical Board certified specialist in general and acute care surgery will be its first Medical Advisor.
MARUX announced that it has filed a provisional patent application with the United States Patent and Trademark Office, covering machine learning, artificial intelligence, and extended/cross-reality for the Company’s remote medical diagnostics, plus remote monitoring application.